“Can the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?”, RSD, vol. 11, no. 11, p. e337111133562, Aug. 2022, doi: 10.33448/rsd-v11i11.33562.